Data Disclosure
In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialisation of prescription-only human pharmaceuticals to healthcare professionals and healthcare organisations.
The disclosed data include transfers of value in four main categories:
| Categories | Transfers of value | |
Healthcare Professionals | Healthcare Organisations | |
| Donations and grants | - | Whether monetary or other |
| Collaborative Working including Joint Working | - | Whether monetary or other |
| Events | 1. Registration fees 2. Travel & accommodation | 1. Sponsorship 2. Registration fees (if applicable) 3. Travel & accommodation |
| Services and consultancy | 1. Fees 2. Related expenses agreed in the contract (including, for example, travel, accommodation & registration fees) | |
| Research and development | Fees, travel & accommodation, and other related expenses that are covered in connection with the service | |
 | Get Access to the UK Data > www.disclosureuk.org.uk |
Learn More About our Disclosure Methodology
The general rules of the EFPIA Disclosure Code apply to all member companies and all companies will disclose transfers of value made to healthcare professionals and healthcare organizations in a pre-defined format. However, some details of the reporting methodology are left for the individual companies to decide in order to allow the necessary flexibility to adjust to the internal processes. This methodology note allows you to understand how Bayer in the UK is documenting and disclosing the relevant information.
PP-OTH-GB-1209 / September 2024